APA (7th ed.) Citation

P, W., B, V., A, P., IC, B., G, G., R, D. C., . . . F, L. (2026). Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: Current evidence and clinical implications. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04350-4

Chicago Style (17th ed.) Citation

P, Willisch, et al. "Androgen Receptor Pathway Inhibitor Intensification in Non-metastatic Hormone-sensitive Prostate Cancer: Current Evidence and Clinical Implications." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04350-4.

MLA (9th ed.) Citation

P, Willisch, et al. "Androgen Receptor Pathway Inhibitor Intensification in Non-metastatic Hormone-sensitive Prostate Cancer: Current Evidence and Clinical Implications." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04350-4.